{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:19:35Z","timestamp":1793884775188,"version":"4.7.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00277-017-3178-4","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T14:35:57Z","timestamp":1510670157000},"page":"343-350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy"],"prefix":"10.1007","volume":"97","author":[{"given":"Si-Ho","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-In","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeri","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungmin","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Eun","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"issue":"5","key":"3178_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","volume":"9","author":"WJ Looney","year":"2009","unstructured":"Looney WJ, Narita M, Muhlemann K (2009) Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9(5):312\u2013323. \nhttps:\/\/doi.org\/10.1016\/S1473-3099(09)70083-0","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"3178_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/CMR.00019-11","volume":"25","author":"JS Brooke","year":"2012","unstructured":"Brooke JS (2012) Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 25(1):2\u201341. \nhttps:\/\/doi.org\/10.1128\/CMR.00019-11","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"3178_CR3","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1086\/522998","volume":"45","author":"A Safdar","year":"2007","unstructured":"Safdar A, Rolston KV (2007) Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45(12):1602\u20131609. \nhttps:\/\/doi.org\/10.1086\/522998","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3178_CR4","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/gb-2008-9-4-r74","volume":"9","author":"LC Crossman","year":"2008","unstructured":"Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N, Adlem E, Kerhornou A, Lord A, Murphy L, Seeger K, Squares R, Rutter S, Quail MA, Rajandream MA, Harris D, Churcher C, Bentley SD, Parkhill J, Thomson NR, Avison MB (2008) The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9(4):R74. \nhttps:\/\/doi.org\/10.1186\/gb-2008-9-4-r74","journal-title":"Genome Biol"},{"issue":"1","key":"3178_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1128\/AAC.01682-13","volume":"58","author":"SY Cho","year":"2014","unstructured":"Cho SY, Kang CI, Kim J, Ha YE, Chung DR, Lee NY, Peck KR, Song JH (2014) Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia? Antimicrob Agents Chemother 58(1):581\u2013583. \nhttps:\/\/doi.org\/10.1128\/AAC.01682-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3178_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1128\/AAC.01324-13","volume":"58","author":"YL Wang","year":"2014","unstructured":"Wang YL, Scipione MR, Dubrovskaya Y, Papadopoulos J (2014) Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. Antimicrob Agents Chemother 58(1):176\u2013182. \nhttps:\/\/doi.org\/10.1128\/AAC.01324-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3178_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0801-7","volume":"15","author":"SY Cho","year":"2015","unstructured":"Cho SY, Lee DG, Choi SM, Park C, Chun HS, Park YJ, Choi JK, Lee HJ, Park SH, Choi JH, Yoo JH (2015) Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations. BMC Infect Dis 15(1):69. \nhttps:\/\/doi.org\/10.1186\/s12879-015-0801-7","journal-title":"BMC Infect Dis"},{"issue":"3","key":"3178_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1086\/314043","volume":"31","author":"A Micozzi","year":"2000","unstructured":"Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, Martino P (2000) Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 31(3):705\u2013711. \nhttps:\/\/doi.org\/10.1086\/314043","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3178_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/00365549409011780","volume":"26","author":"MA Victor","year":"1994","unstructured":"Victor MA, Arpi M, Bruun B, Jonsson V, Hansen MM (1994) Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand J Infect Dis 26(2):163\u2013170. \nhttps:\/\/doi.org\/10.3109\/00365549409011780","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"3178_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1086\/502197","volume":"24","author":"A Apisarnthanarak","year":"2003","unstructured":"Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB (2003) Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol 24(4):269\u2013274. \nhttps:\/\/doi.org\/10.1086\/502197","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6\u20137","key":"3178_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/00365540500452481","volume":"38","author":"G Metan","year":"2006","unstructured":"Metan G, Hayran M, Hascelik G, Uzun O (2006) Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis 38(6\u20137):527\u2013531. \nhttps:\/\/doi.org\/10.1080\/00365540500452481","journal-title":"Scand J Infect Dis"},{"issue":"11","key":"3178_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112208","volume":"9","author":"G Hotta","year":"2014","unstructured":"Hotta G, Matsumura Y, Kato K, Nakano S, Yunoki T, Yamamoto M, Nagao M, Ito Y, Takakura S, Ichiyama S (2014) Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species. PLoS One 9(11):e112208. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0112208","journal-title":"PLoS One"},{"issue":"7","key":"3178_CR13","doi-asserted-by":"publisher","first-page":"e0133731","DOI":"10.1371\/journal.pone.0133731","volume":"10","author":"K Sumida","year":"2015","unstructured":"Sumida K, Chong Y, Miyake N, Akahoshi T, Yasuda M, Shimono N, Shimoda S, Maehara Y, Akashi K (2015) Risk factors associated with Stenotrophomonas maltophilia bacteremia: a matched case-control study. PLoS One 10(7):e0133731. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0133731","journal-title":"PLoS One"},{"issue":"Suppl 4","key":"3178_CR14","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1086\/598188","volume":"48","author":"H Seifert","year":"2009","unstructured":"Seifert H (2009) The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections. Clin Infect Dis 48(Suppl 4):S238\u2013S245. \nhttps:\/\/doi.org\/10.1086\/598188","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3178_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.diagmicrobio.2013.04.014","volume":"76","author":"K Huh","year":"2013","unstructured":"Huh K, Kim J, Cho SY, Ha YE, Joo EJ, Kang CI, Chung DR, Lee NY, Song JH, Peck KR, Korean Network for Study on Infectious Diseases (2013) Continuous increase of the antimicrobial resistance among gram-negative pathogens causing bacteremia: a nationwide surveillance study by the Korean Network for Study on Infectious Diseases (KONSID). Diagn Microbiol Infect Dis 76(4):477\u2013482. \nhttps:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.04.014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"3178_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383. \nhttps:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"issue":"14","key":"3178_CR17","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","volume":"286","author":"FL Ferreira","year":"2001","unstructured":"Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286(14):1754\u20131758. \nhttps:\/\/doi.org\/10.1001\/jama.286.14.1754","journal-title":"JAMA"},{"issue":"11","key":"3178_CR18","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1128\/AAC.00984-16","volume":"60","author":"JY Lee","year":"2016","unstructured":"Lee JY, Kang CI, Ko JH, Lee WJ, Seok HR, Park GE, Cho SY, Ha YE, Chung DR, Lee NY, Peck KR, Song JH (2016) Clinical features and risk factors for development of breakthrough gram-negative bacteremia during carbapenem therapy. Antimicrob Agents Chemother 60(11):6673\u20136678. \nhttps:\/\/doi.org\/10.1128\/AAC.00984-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"3178_CR19","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1128\/AAC.49.9.3980-3981.2005","volume":"49","author":"G Metan","year":"2005","unstructured":"Metan G, Uzun O (2005) Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia. Antimicrob Agents Chemother 49(9):3980\u20133981. \nhttps:\/\/doi.org\/10.1128\/AAC.49.9.3980-3981.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3178_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jinf.2010.10.010","volume":"62","author":"CI Kang","year":"2011","unstructured":"Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Korean Network for Study of Infectious Diseases (2011) Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. J Inf Secur 62(1):26\u201333. \nhttps:\/\/doi.org\/10.1016\/j.jinf.2010.10.010","journal-title":"J Inf Secur"},{"issue":"3","key":"3178_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 43(3):304\u2013377. \nhttps:\/\/doi.org\/10.1007\/s00134-017-4683-6","journal-title":"Intensive Care Med"},{"issue":"1","key":"3178_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/668770","volume":"34","author":"DM Sievert","year":"2013","unstructured":"Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S, National Healthcare Safety Network Team, Participating Nhsn Facilities (2013) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34(1):1\u201314. \nhttps:\/\/doi.org\/10.1086\/668770","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"3178_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-228","volume":"10","author":"JY Jung","year":"2010","unstructured":"Jung JY, Park MS, Kim SE, Park BH, Son JY, Kim EY, Lim JE, Lee SK, Lee SH, Lee KJ, Kang YA, Kim SK, Chang J, Kim YS (2010) Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 10(1):228. \nhttps:\/\/doi.org\/10.1186\/1471-2334-10-228","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3178_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-016-0167-7","volume":"6","author":"R Cohen","year":"2017","unstructured":"Cohen R, Babushkin F, Cohen S, Afraimov M, Shapiro M, Uda M, Khabra E, Adler A, Ben Ami R, Paikin S (2017) A prospective survey of Pseudomonas aeruginosa colonization and infection in the intensive care unit. Antimicrob Resist Infect Control 6(1):7. \nhttps:\/\/doi.org\/10.1186\/s13756-016-0167-7","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"3178_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10096-010-0882-6","volume":"29","author":"H Araoka","year":"2010","unstructured":"Araoka H, Baba M, Yoneyama A (2010) Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009. Eur J Clin Microbiol Infect Dis 29(5):605\u2013608. \nhttps:\/\/doi.org\/10.1007\/s10096-010-0882-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"3178_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10096-006-0243-7","volume":"26","author":"G Aisenberg","year":"2007","unstructured":"Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A (2007) Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. Eur J Clin Microbiol Infect Dis 26(1):13\u201320. \nhttps:\/\/doi.org\/10.1007\/s10096-006-0243-7","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3178-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3178-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3178-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T23:38:07Z","timestamp":1515022687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3178-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["3178"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3178-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]}}}